WAVEMAN · COMPANY
BTAIQ · Bioxcel Therapeutics, Inc.
> Ask across nine datasets ⌘K
LIVE
TEAM-0.26% 13F +439META-2.43% 13F +2,702RCG-0.59% CLUSTERUTHR-0.53% 13F +426CRWV+1.85% 13F +694CRM-2.03% 13F +1,023CVNA-1.11% 13F +798DELL-3.46% 13F +1,206TPL+1.58% 13F +443NET-3.10% 13F +712MSTR+16.39% 13F +525CRWD-3.28% 13F +1,383ANET-0.07% 13F +1,325COIN+11.66% 13F +475TEAM-0.26% 13F +439META-2.43% 13F +2,702RCG-0.59% CLUSTERUTHR-0.53% 13F +426CRWV+1.85% 13F +694CRM-2.03% 13F +1,023CVNA-1.11% 13F +798DELL-3.46% 13F +1,206TPL+1.58% 13F +443NET-3.10% 13F +712MSTR+16.39% 13F +525CRWD-3.28% 13F +1,383ANET-0.07% 13F +1,325COIN+11.66% 13F +475
← ALL COMPANIES

BTAIQ

BioXcel Therapeutics, Inc.
PHARMA & BIOTECH · PHARMACEUTICAL PREPARATIONS · CIK 0001720893
SEC FILINGS☆ WATCH
INSIDER NET · 180D
-
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
0
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
0
13F, latest reported quarter
REVENUE GROWTH
-
XBRL, annual
NET MARGIN
-

WaveMan Stock Sonar 0/7 axes

Profitability
needs 2 of 4 inputs, 0 present: not filed
Financial health
needs 1 of 2 inputs, 0 present: not filed
Growth
needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
Insider conviction
needs 1 of 2 inputs, 0 present: no insider trades in 180 days; no open-market insider trades in 180 days
Institutional and government
needs 1 of 4 inputs, 0 present: fewer than five funds report holding it; no Congress trades in 365 days; no federal contracts in 180 days; no lobbying filings in the last four quarters
Risk and compliance
needs 1 of 4 inputs, 0 present: needs two 10-Ks with a Risk Factors section (not 20-F filers or stubs); no short interest or no free float on file; revenue under $50M or not filed, so a count cannot be scaled to size
Innovation
needs 1 of 1 inputs, 0 present: patent data not loaded yet

0 of 7 axes scored, each a percentile against sector peers (universe where the sector is thin). Higher is better on every axis; an unscored axis is unmeasured, not a low score. How it is scored

Live price
Daily candles from TradingView, on their licence , no filings are marked on this one
WHY THIS NAME IS ON THE DESK
The complete filing record, in one place.
Every figure on this page is a federal filing, dated the day it became public, so you can test what was knowable, not what is known now.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
UTHRCPIXMRNAREGNLLYALNYMDGLCITRDNAVRTXNUVLINSM
Insider transactions
Form 4 purchases and sales (codes P and S), grants, option exercises and preferred conversions excluded

No insider purchases or sales are on record for BioXcel Therapeutics, Inc. in the period covered. Source: SEC Form 4 filings, as of 2026-09-20.

INSIDER
FILED
SHARES
VALUE

no insider purchases or sales on record

0 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see the full history, the screener and CSV export, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported

no 13F holders found for this ticker

SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
FORM 144
No planned-sale notices
No insider has notified an intent to sell. This is the panel to watch after a run-up.